NEWS & PRESS
Solarea Bio Announces Series A Financing
Solarea Bio announced today it has raised $11.2M in a Series A financing led by S2G Ventures and Bold Capital Partners, along with continued investment from Viking Global and additional investment from the Gisev Family Office as a syndicate …
Oct 19 2020
Welcome Solarea Bio: Innovators Unlocking the Power of Microbes to Improve Human Health
S2G’s investment into Solarea provides an opportunity for S2G to support the next wave of functional foods. S2G’s led Solarea’s Series A fundraise with Bold Capital Partners, along with continued investment from Viking Global Investors and the Gisev …
Oct 19 2020
Juliana Soto Named To Georgia Tech Alumni’s 40 Under 40 List
In the U.S., about 10 million Americans are currently living with osteoporosis or osteopenia and the majority are women. For Maria Soto-Giron, that statistic is personal. Her motivation for working in biotech looking for treatments to reduce chronic inflammation is her mother who has rheumatoid arthritis and osteoporosis.
Jul 15 2020
Eric Schott’s Ph.D. work covered by Forbes.
While your body is home to millions of different types of bacteria, it turns out that some may be more welcome than others.
But now we have more reason to believe that specific bacteria living in the gut microbiome may, in fact, be responsible for a common debilitating disease.
Apr 23 2018
Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups
—Solarea Bio: The only company not from the Bay Area, Boston-based Solarea is developing probiotic treatments that are derived from natural sources, Cashin says.
Jul 26 2017